J&J's depression drug Spravato wins European panel vote Reuters
J&J's depression drug Spravato wins European panel vote KFGO News
J&J's depression drug Spravato wins European panel vote WSAU News
J&J's depression drug Spravato wins European panel vote WHTC News
Janssen Receives Positive CHMP Opinion for Spravato® (esketamine) Nasal Spray for Adults with Treatment-Resistant Major Depressive Disorder Business Wire
Global Antidepressants Drugs Market Demand Analysis, Solutions, Industry Challenges and Extension During 2019 – 2025 True Version
Antidepressant Drugs Market Economy, Supply, Research Discoveries with Competitive Dynamics By 2028 Healthcare News
Investors hope psychedelics are the new cannabis. Are they high? The Economist
